Sandy Draper
Stock Analyst at Guggenheim
(2.91)
# 1,447
Out of 5,140 analysts
113
Total ratings
59.14%
Success rate
20.63%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $446.44 | -3.23% | 12 | Jul 24, 2024 | |
| EVH Evolent Health | Maintains: Hold | $34 → $28 | $2.77 | +910.83% | 10 | May 14, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $169.36 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $164.24 | - | 15 | Feb 15, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $2.36 | +323.73% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $25.23 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.60 | -23.08% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $98.41 | +167.25% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $0.40 | +7,320.23% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $78.88 | +19.17% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.88 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $21.83 | +133.62% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $216.36 | -40.38% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $36.28 | +51.60% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $103.29 | +62.65% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $15.82 | -24.15% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $8.91 | +461.17% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $10.01 | +549.35% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $1.86 | +1,835.48% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $182.57 | -8.53% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.84 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $9.19 | +585.53% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $446.44
Upside: -3.23%
Evolent Health
May 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $2.77
Upside: +910.83%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $169.36
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $164.24
Upside: -
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.36
Upside: +323.73%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $25.23
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.60
Upside: -23.08%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $98.41
Upside: +167.25%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $0.40
Upside: +7,320.23%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $78.88
Upside: +19.17%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $4.88
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $21.83
Upside: +133.62%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $216.36
Upside: -40.38%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $36.28
Upside: +51.60%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $103.29
Upside: +62.65%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $15.82
Upside: -24.15%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $8.91
Upside: +461.17%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $10.01
Upside: +549.35%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $1.86
Upside: +1,835.48%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $182.57
Upside: -8.53%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.84
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $9.19
Upside: +585.53%